ARCHIVES

Phase III Nexavar Trial Fails Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Calcium, Vitamin D Provide No Benefit for Colon Cancer

February 24, 2006

Institute of Medicine Elects 80 New Members

October 24, 2014

Eight Years Later:In A Change of Heart, LCA Endorses NLST

April 18, 2014

Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI

August 2, 2002

Funding opportunities listed.

November 12, 2004

Research Opportunities Growing, $$ Shrinking, Young Tells Congress

March 29, 1991